FindTrial
Sign In

LimFlow System

DEVICE4 trials

Sponsors

LimFlow, Inc., LimFlow SA

Conditions

Arterial DiseaseArterial OcclusionArterial Occlusive DiseasesChronic Limb-Threatening IschemiaCritical Limb IschemiaCritical Lower Limb IschemiaPeripheral Arterial DiseasePeripheral Artery Disease

Unknown Phase

PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System
CompletedNCT03124875
LimFlow, Inc.Chronic Limb-Threatening Ischemia, Critical Limb Ischemia
Start: 2017-07-05End: 2021-01-05Updated: 2024-05-21
PROMISE International
CompletedNCT03321552
LimFlow SACritical Limb Ischemia
Start: 2017-12-15End: 2025-01-23Updated: 2026-01-07
Percutaneous Deep Vein Arterialization Post-Market Study
CompletedNCT03807661
LimFlow SACritical Limb Ischemia
Start: 2019-12-11End: 2024-10-28Updated: 2026-01-16
PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Active, not recruitingNCT03970538
LimFlow, Inc.Arterial Disease, Arterial Occlusion, Arterial Occlusive Diseases +9
Start: 2019-12-06End: 2025-02-28Updated: 2024-02-28

Related Papers

Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia
New England Journal of Medicine2023-03-29120 citations
PROMISE international; a clinical post marketing trial investigating the percutaneous deep vein arterialization (LimFlow) in the treatment of no-option chronic limb ischemia patient
CVIR Endovascular2019-07-3114 citations